Work

Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine

Year: 2019

Type: review

Source: Current Opinion in Immunology

DOI: 10.1016/j.coi.2019.02.009

Authors: Thomas C Heineman, Anthony Cunningham, Myron Levin

Institutions: Halozyme Therapeutics (United States), The University of Sydney, Westmead Institute for Medical Research, University of Colorado Anschutz

Language: English

Topic: Herpesvirus Infections and Treatments

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2936540010

FWCI: 1.678

Cites: 36

Cited by: 127

Related to: 10